AzTrials
AzTrials

Hallux ValgusNCT07177768

Acute Effects of Prolonged Walking on Hallux Valgus

A study testing Prolonged walking in people with Hallux Valgus, run by Bezmialem Vakif University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Hallux valgus is a progressive foot deformity characterized by lateral deviation of the great toe and medial displacement of the first metatarsal head. While pain is a common symptom among individuals with HV, alterations in plantar pressure distribution and impaired balance are also frequently observed. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Hallux Valgus
What is being tested?
Prolonged walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteTurkey (Türkiye)
Study dates
Oct 2025to Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Hallux Valgus Group Criteria:
  • Individuals aged between 18 and 55 years
  • Being diagnosed with hallux valgus
  • Control Group Criteria:
  • Individuals aged between 18 and 55 years
  • Classified as grade A according to the Manchester Scale
  • Being a volunteer

Who cannot join

  • History of previous foot or ankle surgery
  • Having a systemic diseases
  • Having a neurological disorders
  • Having a vestibular pathologies that may affect balance

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Bezmialem Vakif University

    Istanbul, Eyup

Other trials in Turkey (Türkiye)

About this study

Official title: Acute Effects of Prolonged Walking on Pain, Balance and Posture in Individuals With Hallux Valgus Deformity

Hallux valgus is a progressive foot deformity characterized by lateral deviation of the great toe and medial displacement of the first metatarsal head. While pain is a common symptom among individuals with HV, alterations in plantar pressure distribution and impaired balance are also frequently observed. These symptoms and biomechanical changes can negatively impact posture and gait mechanics. The aim of this study is to investigate the acute effects of prolonged walking on pain, balance, posture, and gait in individuals with hallux valgus deformity.

Read the detailed description

Hallux valgus is a progressive foot deformity commonly seen in adults. Patients typically report pain, most prominently in the first metatarsophalangeal joint, which is often exacerbated by weight-bearing activities such as walking. Due to the deformity, alterations in plantar pressure distribution occur, which in turn affect plantar sensory input and postural control. This may lead to decreased postural stability, impaired balance, and compromised control during walking. HV is also thought to accelerate biomechanical changes that negatively impact gait patterns. The aim of this study is to evaluate the acute effects of prolonged walking on pain, balance, posture, and gait in individuals with hallux valgus deformity. A total of 32 participants, including individuals with HV and healthy controls, will be included in the study. All participants will walk on a treadmill for 60 minutes. Assessments will be conducted at three time points: before walking, immediately after walking, and 20 minutes post-walking.

Conditions
Hallux Valgus
Being tested
Prolonged walking
Medical subject headings
Hallux Valgus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prolonged walkingOther

    walking on a treadmill for 60 minutes

Study groups in NCT07177768
Study groupRoleWhat they receive
Hallux Valgus GroupExperimentalIndividuals with hallux valgus deformity
Receives: Other: Prolonged walking
Control GroupOtherHealthy controls
Receives: Other: Prolonged walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Pain intensity will be evaluated with visual analog scale (VAS). Patients will be asked to mark the intensity of the pain they feel on a 10 cm line, where "0" means no pain and "10" means the worst pain.

    Measured: Baseline, immediately after intervention, 20 minutes after intervention

  2. Pressure pain threshold

    It will be measured with algometer. Higher values indicate a higher perceived pain threshold.

    Measured: Baseline, immediately after intervention, 20 minutes after intervention

  3. Single-leg stance test

    The single leg stability will be assessed by using Biodex Balance System® (Biodex Medical Systems, Inc. USA). Low values of the stability index indicate better balance and stability.

    Measured: Baseline, immediately after intervention, 20 minutes after intervention

  4. Postural Assessment

    Posture will be assessed using mobile application. It marks and measures angles at the ear, shoulder, anterior superior iliac spine (ASIS), knee, and ankle alignment to identify any pathological deviations or asymmetries.

    Measured: Baseline, immediately after intervention, 20 minutes after intervention

  5. Gait analysis

    Gait analysis will be performed using mobile application. Subjects are asked to walk at their normal walking speed over a 10-meter surface, and measurements are taken using video recording and evaluated using the software. The assessment records right and left step lengths, double step length, stride width, and walking speed.

    Measured: Baseline, immediately after intervention, 20 minutes after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2025
  2. Study startOct 2025 (estimated)
  3. Primary completionMar 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07177768
Sponsor's protocol ID
KA25-2
Status last verified
Sep 2025
First submitted
10 Sep 2025
Last updated
17 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Prolonged walking in people with Hallux Valgus, run by Bezmialem Vakif University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kubra Alpay, PhD (+902124012600 ext. 4638, kalpay@bezmialem.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline, immediately after intervention, 20 minutes after intervention). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in